Evidence map›Paper›PMID 21227907›Full record

ArticleToxicological sciences : an official journal of the Society of Toxicology2011

Selective phthalate activation of naturally occurring human constitutive androstane receptor splice variants and the pregnane X receptor.

Joshua G DeKeyser, Elizabeth M Laurenzana, Eric C Peterson, Tao Chen, Curtis J Omiecinski

Open access · greenAbstract read
In one paragraph

Article in Toxicological sciences : an official journal of the Society of Toxicology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 1 pooled it
7.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 1 synthesis or guideline pooled it, 94 citations in OpenAlex.

  1. An updated systematic review on the possible effect of nonylphenol on male fertility.Environmental science and pollution research international · 2017
    Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Intrahepatic cholestasis of pregnancy.Nature reviews. Disease primers · 2025
    Review
  7. Article
  8. Article
  9. Article
  10. Are BPA Substitutes as Obesogenic as BPA?International journal of molecular sciences · 2022
    Review
  11. Article
  12. Article
  13. Review
  14. Sources of Interindividual Variability.Methods in molecular biology (Clifton, N.J.) · 2021
    Article
  15. Review
  16. Review
  17. Xenobiotic Receptors and Their Mates in Atopic Dermatitis.International journal of molecular sciences · 2019
    Review
  18. Article
  19. Article
  20. Impact of CAR Agonist Ligand TCPOBOP on Mouse Liver Chromatin Accessibility.Toxicological sciences : an official journal of the Society of Toxicology · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Joshua G DeKeyserCenter for Molecular Toxicology and Carcinogenesis, Department of Veterinary and Biomedical Sciences, Pennsylvania State University, University Park, Pennsylvania 16802, USA.
Elizabeth M Laurenzana
Eric C Peterson
Tao Chen
Curtis J Omiecinski
Pennsylvania State University · US

Funding

Targeting Dynamics of CAR and PXR in the Mouse and Human GenomesR01GM066411 · NIGMS · PENNSYLVANIA STATE UNIVERSITY-UNIV PARK · PI OMIECINSKI, CURTIS J · 2002 to 2017
$4.5M
NIGMS NIH HHS R01 GM066411
6 · The paper itself

Abstract

Phthalates and other endocrine-disruptive chemicals are manufactured in large quantities for use as plasticizers and other commercial applications, resulting in ubiquitous human exposure and thus, concern regarding their toxicity. Innate defense against small molecule exposures is controlled in large part by the constitutive androstane receptor (CAR) and the pregnane X receptor (PXR). The human CAR gene undergoes multiple alternative splicing events resulting in the CAR2 and CAR3 variant receptors. Recent studies from our laboratory show that CAR2 is potently and specifically activated by di(2-ethylhexyl) phthalate (DEHP). We hypothesized that alternative splicing is a mechanism for increasing CAR's functional diversity, broadening the human receptors' repertoire of response to environmental xenobiotics. In these studies, we examine the interaction of alternatively spliced CARs and PXR with a range of suspected endocrine disruptors, including phthalates, bisphenol A (BPA), and 4-N-nonylphenol (NP). Transactivation and two-hybrid studies in COS-1 cells revealed differential selectivity of endocrine-disrupting chemicals for the variant CAR and PXR. Ex vivo studies showed DEHP and di-isononyl phthalate potently induced CYP2B6 and CYP3A4 expression in human hepatocytes. Mutation analysis of CAR2, in silico modeling, and ligand docking studies suggested that the SPTV amino acid insertion of CAR2 creates a unique ligand-binding pocket. Alternative gene splicing results in variant CAR receptors that selectively recognize phthalates and BPA. The interaction of phthalates with CAR and PXR suggests a xenobiotic response that is complex and biologically redundant.

Indexed as

Alternative SplicingAnimalsAryl Hydrocarbon HydroxylasesBlotting, WesternCell Culture TechniquesChlorocebus aethiopsConstitutive Androstane ReceptorCOS CellsCytochrome P-450 CYP2B6Cytochrome P-450 CYP3ADiethylhexyl PhthalateEndocrine DisruptorsEnzyme InductionHepatocytesHumansLigandsAryl Hydrocarbon HydroxylasesConstitutive Androstane ReceptorCYP2B6 protein, humanCYP3A4 protein, humanCytochrome P-450 CYP2B6Cytochrome P-450 CYP3ADiethylhexyl PhthalateEndocrine DisruptorsLigandsOxidoreductases, N-DemethylatingPregnane X ReceptorProtein IsoformsReceptors, Cytoplasmic and NuclearReceptors, Steroid

Identifiers

PMID21227907
PMCPMC3107492
OpenAlexW2156398463

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.